Cervical Cancer Screening in Developing Countries
The Papanicolaou cervical cancer screening test has made a significant contribution to the reduction of human cancer.
As the leading national organization promoting and advocating for cytopathology, the American Society of Cytopathology endorses the screening of women for cervical cancer as well as introduction of HPV vaccination in those populations that are at risk for developing cervical cancer due to exposure to high risk human papillomavirus. Vaccination and screening optimally occur in two distinct populations; vaccination in sexually naïve individuals and screening in HPV exposed populations. The American Society of Cytopathology endorses world wide screening for all women, using the Papanicolaou test, or other appropriate technologies in conjunction with HPV vaccination to prevent, detect and reduce cervical cancer.
Approved by the ASC Executive Board May 2009
Annual Scientific Meeting
Join the more than 800 attendees to learn the newest information and technology in ...
eJournal
We are proud to offer you the only online cytology journal club that reviews the most current ...
Case Studies
Case Studies provide an interactive distance-learning experience to interesting cases...
PEC
The Progressive Evaluation of Competency (PEC) is designed to track the progress of pathology residents & cytopathology fellows through the year...
Cytoteleconference
Designed with your convenience in mind, these 60-minute multi-media teleconferences address...
Archived Cytoteleconferences
Earn CME any time and any place. The ASC provides selections of the Cytoteleconference Series as links.
Web Atlas Bethesda System
Consisting of 349 images representing a range of morphologic findings the Web Atlas Bethesda System...
read more
